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Incidence of bacteremia in
antiretroviral-naive HIV-positive
children less than ﬁve years of age in
Benin City, Nigeria
B
acteremia refers to the presence of bacteria in the
blood, which usually occurs when pathogens gain
entrance to the blood stream through abscesses,
infected wounds or burns or from areas of localized
disease (1). In human immunodeficiency virus (HIV)
infected children, bacterial infections are a major source
of morbidity and mortality. The most common opportu-
nistic infections in children in the absence of Highly
Active Antiretroviral Therapy (HAART) include pneu-
monia and bacteraemia (2).
However, in developing countries where access to care
and treatment for HIV-positive children may be limited,
bacterial invasion of the blood stream becomes readily
possible due to the low immunity of such children. This
report investigates the bacterial etiology of bacteremia
and the antimicrobial susceptibility of causative agents in
antiretroviral-naive HIV-positive children, in Benin City,
Nigeria.
A total of 415 HIV-positive children (229 males and
186 females) were recruited for this study. HIV tests were
done for children less than/or 18 months of age by PCR
method, and for children above 18 months by rapid test
algorithm method. Blood culture test was carried out on
all patients using standard bacteriological methods.
Briefly, glucose broth and thioglycollate broth were
inoculated with 3 ml each of patient’s blood and
incubated at 37 8C initially for 1224 hours, within which
sub-cultures were made by inoculating blood agar,
MacConkey agar, and chocolate agar. The plates were
incubated aerobically in an atmosphere of carbon (IV)
oxide. Another set of plates were incubated anaerobically.
Broth cultures without growth were incubated for a
period of 10 days. Identification of isolates was carried
out by standard methods (3). Antibiotic disc suscept-
ibility testing was carried out using NCCLS standard
operating procedure (4).
Bacterial isolates were detected in 37.1% (154/415) of
HIV-positive blood samples examined. Staphylococcus
aureus was found in 14% (58/415) of samples, Escherichia
coli in 8% (33/415), Klebsiella species in 4.8% (20/415),
Proteus species 3.4% (14/415), coagulase-negative staphy-
lococci in 2.9% (12/415), Pseudomonas aeruginosa in 2.2%
(9/415), and Citrobacter species in 1.9% (8/415).
A prevalence of 37.1% of different types of bacteria
was recorded in this work. This is far more than the
15.5% reported from rural Kwa-Zulu Natal hospital in
South Africa (5). The reason for this high prevalence
could be attributed to the fact that the study population
was infants and young children who were antiretroviral-
naive patients with tendency to suppressed immunity. The
frequency of bacterial isolates from this report showed
S. aureus to be the most predominant organism. This
high prevalence of staphylococcal bacteremia could be
attributed to the high frequency with which scabies and
impetigo interact to cause skin disease in children in
developing countries (6).
The overall in-vitro antimicrobial susceptibility pattern
showed that ciprofloxacin was the most effective and was
closely followed by ceftriaxone (Table 1). However, high
bacterial resistance was shown with ampicillin, cloxacil-
lin, and erythromycin. The upsurge in the antibiotic
resistant pattern seen in this study could be due to
antibiotic abuse and self-medication being practiced in
many developing countries including Nigeria. In such
places, drugs are easily purchased over the counter
without any prescription. Moreover, the low cost and
availability of these drugs could be another contributing
factor to antibiotic resistance in this locality.
In conclusion, the findings of this study revealed that
bacteremia is common amongst antiretroviral-naive HIV-
positive children less than five years of age. S. aureus was
the most predominant organism detected. Ciprofloxacin
and ceftriaxone were the most effective antibiotics in this
study for the treatment of bacteremia in antiretroviral-
naive HIV-positive children from this locality.
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Table 1. Antimicrobial susceptibility of bacterial isolates from bacteremic HIV-positive children in Benin City, Nigeria
No (%) susceptible to
Bacteria No tested AMP CLX ERY GEN CRO CIP
Staphylococcus aureus 58 1 (1.7) 3 (5.2) 8 (13.8) 25 (43.1) 45 (77.6) 47 (81.0)
Coagulase-negative staphylococci 12 2 (16.7) 3 (25.0) 4 (33.3) 6 (50.0) 12 (100) 12 (100)
Escherichia coli 33 2 (6.1) 6 (18.2) 10 (30.3) 20 (60.6) 32 (97) 32 (97.0)
Klebsiella species 20 0 (0) 2 (10.0) 4 (20.0) 12 (60.0) 19 (95) 20 (100)
Proteus species 14 0 (0) 1 (7.1) 2 (14.3) 7 (50.0) 14 (100) 14 (100)
Citrobacter species 8 1 (12.5) 2 (25.0) 2 (25.0) 4 (50.0) 8 (100) 8 (100)
Pseudomonas aeruginosa 9 0 (0) 0 (0) 0 (0) 1 (11.1) 7 (77.8) 8 (88.9)
Total 154 6 (3.9) 17 (11.0) 30 (19.5) 75 (48.7) 137 (89) 141 (91.6)
Note: AMP, ampicillin; CLX, cloxacillin; ERY, erythromycin; GEN, gentamicin; CRO, ceftriaxone; CIP, ciprofloxacin.
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